Navigation Links
Short-Term, Early HRT May Cut Women's Alzheimer's Risk: Study
Date:10/25/2012

By Barbara Bronson Gray
HealthDay Reporter

WEDNESDAY, Oct. 24 (HealthDay News) -- It is said that timing is everything. When it comes to taking hormone replacement therapy, that may indeed be true.

A new study has found that taking hormone replacement therapy within five years of menopause may reduce the risk of developing Alzheimer's disease by 30 percent compared to women who have not used hormone therapy.

The researchers set out to better understand why some previous studies had shown hormones were effective in reducing Alzheimer's risk while others had not.

The Women's Health Initiative Memory Study, a large, multicenter trial, was stopped prematurely in 2002 due to concerns that the hormones might be raising the risks of cardiovascular disease, cancer and dementia.

"The Women's Health study put a cloud over doing further research," said Peter Zandi, author of the latest study and an associate professor at Johns Hopkins University Bloomberg School of Public Health, in Baltimore. "But there was still some mystery: Why were those results so different?"

The new study, performed by a different team of researchers, expanded the previous research by including up to seven years of additional follow-up and more detailed data on the duration, type and timing of hormone therapy.

The new research was published online Oct. 24 in the journal Neurology.

"We found there is likely a critical window after menopause when hormone therapy may be beneficial," Zandi said. "But if started later after menopause, hormones may actually increase the risk of developing Alzheimer's."

Why might that timing be important?

"We don't really know, but we have some ideas," Zandi said. "Around menopause there's a sudden decline in endogenous estrogens, and that may have some provocative effect. Alzheimer's is a chronic disease that most likely has roots in middle age, or earlier." Endogenous estrogens are those that are made naturally by the body.

The researchers followed nearly 1,800 women from Cache County, Utah, aged 65 and older, for 11 years. The participants provided a history of their hormone therapy use and the approximate date when menopause began.

In all, more than 1,100 participants had used hormone therapy, either consisting of estrogen alone or in combination with progestin. During the study, 7.9 percent of the women who had taken hormones developed Alzheimer's disease compared with 13.4 percent of the women who had not.

Although those who had begun hormone therapy within five years of menopause had a 30 percent lower risk of Alzheimer's than those who had not used hormones, a higher risk of dementia was observed among women who had started a combined therapy of estrogen and progestin when they were 65 or older.

The U.S. Preventive Services Task Force, an independent group of national experts in prevention and evidence-based medicine, issued a final statement Oct. 23 recommending against the use of hormone therapy to prevent chronic conditions such as heart disease or dementia in women who had experienced menopause.

Given that recommendation, and the wide range of research about hormone replacement therapy, what should women do?

Dr. Victor Henderson, professor of neurology and health research and policy at Stanford University, said the research shouldn't spur women to take hormone therapy in an effort to cut their risk of getting Alzheimer's.

"I don't think the message is that women of any age should take the hormones to reduce dementia risk," he said.

Henderson, who wrote an accompanying editorial in same journal issue, urged caution: "More research is needed before we can make new recommendations for women about their use of hormone replacement therapy," he said.

More information

Learn more about hormone replacement therapy from the U.S. National Library of Medicine.

SOURCES: Peter Zandi, Ph.D., associate professor, department of mental health, Johns Hopkins University, Baltimore; Victor Henderson, M.D., M.S., professor, health research and policy, and neurology, Stanford University, Palo Alto, Calif.; Oct. 23, 2012, press release, U.S. Preventive Services Task Force; Oct. 24, 2012, Neurology


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Stool Test Might Aid in Early Detection of Colon Cancer
2. An Early Start for Your Child with Autism
3. Early Study Finds Some Promise for Lung Cancer Vaccine
4. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
5. JCI early table of contents for April 9, 2012
6. Eye Tremors May Aid Early Diagnosis of Parkinsons: Study
7. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
8. First contact: Early intervention key in diagnosis and treatment of serious mental illness
9. Brain Tumor Vaccine Shows Promise in Early Trial
10. Role of Screening, Monitoring in Early Kidney Disease Unclear
11. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Short-Term, Early HRT May Cut Women's Alzheimer's Risk: Study
(Date:12/7/2016)... Honolulu, HI (PRWEB) , ... December 07, 2016 ... ... Dermatology is proud to announce that its fully redesigned website, which launched October ... well as a sleek responsive design and easy-to-navigate layout. Visitors and patients can ...
(Date:12/7/2016)... ... 2016 , ... Texas Premier Locksmith , a leading ... unethical locksmith companies and is urging Search Engines to improve verification methods in ... Locksmith, these fraudulent locksmith services take advantage of consumers locked out of houses, ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX ... media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes ... use drop zones. Editors can select from a variety of flip book animations. In ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, ... at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of ... acupuncturists to help patients realize their family building goals. Acupuncture helps fertility ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Walking With God: Inspirational Lessons from My Life's ... reader to be aware of God's direction in their lives. “Walking With God: Inspirational ... teacher and active church leader. , Sanford says, “I enjoy sharing the ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... YORK , Dec. 7, 2016 ... report on pulmonary drugs studies the current as ... The stakeholders of this report include companies and ... various pulmonary/respiratory drugs and/or drug-device combinations as well ... This report comprises an elaborate executive summary along ...
(Date:12/7/2016)... , Dec. 7, 2016  The Corporate Whistleblower ... manager to call them anytime at 866-714-6466 if they ... to sell more drugs. Aside from the innocent patients ... as well, because often-times these practices target Medicare recipients or ... ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
Breaking Medicine Technology: